Stay updated on Nivolumab and Ipilimumab in ACC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in ACC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Ipilimumab in ACC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A new Revision: v3.3.4 label was added and the previous Revision: v3.3.3 label was removed, indicating a minor site revision. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:54:52.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    An updated status block was added, displaying Northwestern University as sponsor and the last known status with a verification date (2023-12).
    Difference
    0.4%
    Check dated 2026-01-07T00:33:55.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Locations section is reorganized under a general 'Locations' header and now lists Illinois as a study site, replacing the previous 'Illinois Locations' heading. The footer 'HHS Vulnerability Disclosure' link was removed and the revision label updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T13:27:31.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Publications section now clarifies that entries are automatically filled from PubMed and may not all pertain to the study. A revision tag 'Revision: v3.3.2' is displayed.
    Difference
    0.1%
    Check dated 2025-11-24T21:51:40.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Removed a government funding–related notice stating information may not be up to date; study details on the page remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T20:05:01.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Minor formatting tweaks and updates to non-critical metadata were observed, and core study details such as title, NCT number, objectives, eligibility criteria, and primary outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:52:53.000Z thumbnail image

Stay in the know with updates to Nivolumab and Ipilimumab in ACC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in ACC Clinical Trial page.